Alemtuzumab

**Definition:** An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.

**Tree numbers:** - D12.776.124.486.485.114.224.060.313 - D12.776.124.790.651.114.224.060.375 - D12.776.377.715.548.114.224.200.375